Karyopharm Therapeutics Inc (KPTI) — Capital Reinvestment Ratio

Latest as of December 2021: 0.01x

Karyopharm Therapeutics Inc (KPTI) has a Capital Reinvestment Ratio of 0.01x as of December 2021, meaning it reinvests 0% of its operating cash flow ($25.48 Million) in capital expenditures ($207.00K). See KPTI net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$25.48 Million

USD

Capital Expenditures

$207.00K

USD

Data as of

Dec 2021

Most recent filing

Annual Capital Reinvestment Ratio for Karyopharm Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Karyopharm Therapeutics Inc from None to None. For live market cap and broader valuation context, see market value of Karyopharm Therapeutics Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow